Tag: Diabetes Management

Benefits of the Guardian Connect System

Benefits of the Guardian Connect System

April 06, 2022

Are you looking for a way to help outsmart your diabetes? Medtronic Guardian™ Connect CGM is the answer!

The Guardian™ Connect system is the first and only standalone Smart* Continuous Glucose Monitoring system that can predict high and low sensor glucose events up to 60 minutes in advance.

benefits of the guardian connect, why use a Medtronic cgm

What Is the Guardian™ Connect System?

When using the Guardian™ Connect system you can:

  • See current glucose levels and trends at any time right on your smartphone

  • Get alerts – including predictive alerts up to 60 minutes in advance – of high and low glucose events*

  • Connect with care partners and healthcare professionals (HCPs) via the CareLink™ system platform

  • Access the Sugar.IQ™ diabetes assistant app for iOS users

The Guardian™ Connect system is the only CGM system with customizable predictive alerts that help you avoid both highs and lows. Using smart technology to predict where your glucose levels are headed, the system can alert you from 10 to 60 minutes before a high or low.

Exclusively available to patients using the Guardian™ Connect system, the Sugar.IQ™ diabetes assistant app (currently only available on iOS) analyzes how glucose levels react to food, exercise, and insulin. Together, the Guardian™ Connect system and the Sugar.IQ™ app turn hidden patterns into personalized insights that can help you make smarter diabetes decisions.1

benefits of the guardian connect, why use a Medtronic cgm

Learn More about the Guardian Connect

Apply Today

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.

* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance. Based on sensor glucose values with alerts turned on.

Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.

Tags: , , ,

Related Articles

Insulin Pump Therapy: MiniMed™ 770G Pump from Medtronic

Insulin Pump Therapy: MiniMed™ 770G Pump from Medtronic

April 04, 2022

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

See Your Sugar Levels And Insulin Delivery Right On Your Smartphone!

The MiniMed™ 770G system, sometimes referred to as a hybrid closed loop system, automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOs and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

 

Learn How The MiniMed™ 770G Pump from Medtronic Can Help You Prevent Glucose Highs And Lows!

Ready to get started?

Apply Today

** Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 

Tags: , , , , ,

Related Articles

The Future Is Now

The Future Is Now

April 04, 2022

Knowing your blood glucose numbers is key to managing diabetes successfully, but it can be tricky to test your blood sugar as often as you should.

Not knowing can lead to guessing insulin doses, erratic blood sugar, and out-of-control A1C levels.

But a continuous glucose monitoring (CGM) system like the Dexcom G6 helps eliminate the mystery and empowers you with the data needed to control your blood sugar levels, spot trends in how your body responds to different situations, and ultimately better manage your diabetes.

With features ranging from customizable alerts and alarms to the ability to share your numbers with up to 10 followers, the Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2 All of this without fingersticks!

The Dexcom G6 system is an easy-to-use CGM that consists of the following components:

  • A simple auto-applicator easily inserts a small sensor just beneath the skin

  • The sensor and transmitter work together to continuously measure glucose levels and send data wirelessly to the display device

  • Your display device (either the Dexcom receiver or a compatible smart device**) displays real-time glucose data

The Diabetes Care team at EHCS is ready to help you get your Dexcom G6. We work with hundreds of insurances, including Medicare and Medicaid. As a leader in diabetes care for more than 25 years, we truly understand the importance of quality products like the Dexcom G6 with personalized care. Click below to find out if you qualify for a Dexcom G6 system. After you complete the online application, EHCS will pair you with a dedicated Diabetes Care Advisor (DCA) to help you through the process. Our team of DCAs is your guide to better diabetes control from insurance approval to future supply reorders and will guide the way to better health.

Learn More about the Guardian Connect

Apply Today

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.

* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance. Based on sensor glucose values with alerts turned on.

Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.

Tags: , , , ,

Related Articles

Benefits of a MiniMed Insulin Pump

Benefits of a MiniMed Insulin Pump

April 04, 2022

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs.

Medtronic’s selection of insulin pumps gives you the flexibility to continue living your life while managing your diabetes!

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

But a continuous glucose monitoring (CGM) system like the Dexcom G6 helps eliminate the mystery and empowers you with the data needed to control your blood sugar levels, spot trends in how your body responds to different situations, and ultimately better manage your diabetes.

With features ranging from customizable alerts and alarms to the ability to share your numbers with up to 10 followers, the Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2 All of this without fingersticks!

The Dexcom G6 system is an easy-to-use CGM that consists of the following components:

  • A simple auto-applicator easily inserts a small sensor just beneath the skin

  • The sensor and transmitter work together to continuously measure glucose levels and send data wirelessly to the display device

  • Your display device (either the Dexcom receiver or a compatible smart device**) displays real-time glucose data

The Diabetes Care team at EHCS is ready to help you get your Dexcom G6. We work with hundreds of insurances, including Medicare and Medicaid. As a leader in diabetes care for more than 25 years, we truly understand the importance of quality products like the Dexcom G6 with personalized care. Click below to find out if you qualify for a Dexcom G6 system. After you complete the online application, EHCS will pair you with a dedicated Diabetes Care Advisor (DCA) to help you through the process. Our team of DCAs is your guide to better diabetes control from insurance approval to future supply reorders and will guide the way to better health.

Why Choose a Medtronic Insulin Pump?
Medtronic has more than 35 years of experience, over 1.2 million people living with diabetes served, and offers service and support to help you succeed with your new insulin pump therapy! Medtronic’s systems include intuitive features that help you manage your diabetes better.

SmartGuard™ Auto Mode
The MiniMed™ 670G system is the only system that automatically adjusts background insulin every five minutes based on your sugar levels.†

Benefits of the SmartGuard™ Auto Mode include:

  • Fewer highs and lows 3

  • Personalized diabetes management 3

  • More freedom to focus on your day 3, 9

  • Less effort to manage diabetes 9

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

Service and Support

  • 24-Hour Technical Support to answer your questions

  • Largest support team consisting of over 2,000 field, clinical and customer care representatives

  • Personalized education and training programs

  • Dedicated insurance service teams to support your insurance needs

Exclusive CareLink™ Software

  • A web-based program that collects information directly from your Medtronic diabetes management system. It allows you to generate reports that can be used during your doctor’s visits and to monitor your own progress.

Learn More about the Guardian Connect

Apply Today

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.

* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance. Based on sensor glucose values with alerts turned on.

Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.

Tags: , , , , ,

Related Articles

Are You Ready for an Insulin Pump?

Are You Ready for an Insulin Pump?

April 04, 2022

Insulin pump therapy is a safe and simple way to achieve tight glucose control. Studies have shown better outcomes when using insulin pumps. And while it does allow for more flexibility in lifestyle and the potential to even out the wide blood sugar fluctuations that are often experienced when injecting insulin, it may not be the right choice for every person. But how do you know?

How Can an Insulin Pump Help Me?

The insulin pump gives you a constant drip of insulin all day long, similar to what a normal pancreas would do. This is called the basal rate. Basal insulin needs may vary throughout the day. Similar to the size to a pager, an insulin pump is battery-operated and can be programmed to meet your individual needs. If your basal rate is calculated correctly, you should be able to delay or even skip meal and still have a normal blood glucose levels. In response to a meal, a normal pancreas will secrete a bolus of insulin to match the glucose load resulting from that meal. With insulin pump therapy, you calculate how much insulin you will need based on the carbohydrate content of your meal.

For example, let’s assume you need one unit of insulin for every ten grams of carbohydrate you eat and your meal contains 60 grams of carbohydrates. You would divide 60 by 10 and get 6. Then you would program the pump to deliver a bolus of 6 units of insulin for that meal.

Only rapid-acting insulins are used in insulin pumps, which allow you to more closely mimic normal physiology. If you are interested in gaining tighter glucose control and more flexibility in your life-style, then insulin pump therapy may be right for you. View our full range of insulin pumps here.

Why Order From EHCS?

Learn More About Us

Why Should I Use Edwards Health Care Services (EHCS)?

Since 1992, EHCS has been in the business of diabetes care and supplies offering a wide range of diabetes products, including glucose monitoring equipment, insulin pumps, testing and pump supplies. EHCS is committed to helping improve the quality of life for our customers living with diabetes by offering:

  • Order reminder program

  • Free nationwide delivery

  • Easy ordering by phone, web and email

  • Simple billing process

Tags: , , , ,

Related Articles

What is V-Go Insulin Delivery?

What is V-Go Insulin Delivery?

April 04, 2022

V-Go is designed to fit easily into your life and help you manage diabetes by combining all of your insulin needs into one simple device you apply like a patch.

Designed to deliver insulin like your body does — gradually, during the day and night

What is V-Go?

Freedom to live without insulin pens or syringes.

Designed to replace both your long-acting basal insulin and your multiple mealtime insulin injections, V-Go delivers a continuous basal insulin rate over 24 hours that mimics the body’s natural approach to all-day-and-night blood sugar control. With a continuous, preset rate of fast-acting insulin along with convenient, on-demand dosing at mealtimes (bolus dosing). V-Go is designed to provide all of your insulin needs throughout the day. Studies have shown that V-Go provides better control of blood sugar levels than multiple daily insulin injections.1

V-Go provides insulin in two ways, similar to how your body provides insulin*. It provides a steady rate of background insulin over 24 hours and provides additional insulin at mealtimes without anyone knowing by discreetly clicking a button.

By using V-Go, you can live your life on the go without interrupting your day to gather supplies or look for a private place to give yourself an injection.

All you do is fill the device with insulin, clean the spot where you want to wear it, stick it on, and you’re set for 24 hours. It brought my A1c from 10.8 down to 6.0 in about 2 months. (Individual results may vary)

CLARK, AGE 65

Learn More About V-Go

Learn More

Ready to get started with V-Go insulin delivery?

If you have Type 2 diabetes and are taking multiple daily injections, the V-Go insulin delivery system may be the perfect solution for you. Our Diabetes Care team at our sister company, GEM Edwards Pharmacy, focuses on personalized care and will walk you through the entire process. Visit GEM Edwards Pharmacy or call 1.866.552.5522 to get started.

* Instructions for Patient Use
References: 1. Lajara R, Nikkel C. Poster presented at: the International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting; May 2017; Boston, MA.

Important Risk Information
If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

Tags: , , , , ,

Related Articles

V-Go Insulin Delivery Lets You Focus More on Living Your Life

V-Go Insulin Delivery Lets You Focus More on Living Your Life

April 04, 2022

If you have Type 2 diabetes and are taking multiple daily injections, the V-Go insulin delivery system may be the perfect solution for you.

V-Go is easy to use with a once-daily application and a few simple clicks, providing blood sugar control that fits your unpredictable everyday life.

Just fill, wear and go with V-Go!

Finally, simple, convenient all-day-and-night insulin delivery you apply once daily. With V-Go, you can have:

•  Improved blood sugar control as compared to prior use with multiple daily insulin shots 1

•  A treatment option you apply like a patch

•  No need for long-acting insulin

•  Insulin delivered the way your body is supposed to, gradually, day and night

When I have V-Go on, I truly forget that it’s there. (Individual results may vary)

Debbie, dropped A1C below 7

Learn More About V-Go

Learn More

Three simple steps to use V-Go

1. Fill V-Go: First, just fill the V-Go with fast-acting insulin. It takes less than a minute to prepare V-Go for 24-hour use.

2. Wear V-Go: V-Go can be worn in a variety of locations on the body, and the location can be changed based on preference or clothing choice each day.

3. And just GO! With the simple click of a button, you’ll be able to give yourself mealtime insulin whenever you need it. No more supplies and no more interruptions to your day. Now you can focus on your life and not your insulin.

Ready to get started with V-Go insulin delivery?

If you have Type 2 diabetes and are taking multiple daily injections, the V-Go insulin delivery system may be the perfect solution for you. Our Diabetes Care team at our sister company, GEM Edwards Pharmacy, focuses on personalized care and will walk you through the entire process. Visit GEM Edwards Pharmacy or call 1.866.552.5522 to get started.

* Instructions for Patient Use
References: 1. Lajara R, Nikkel C. Poster presented at: the International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting; May 2017; Boston, MA.

Important Risk Information
If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

Tags: , , , , ,

Related Articles

How does an insulin pump work?

How does an insulin pump work?

April 04, 2022

Your primary goal to successfully managing your diabetes, is getting your blood glucose levels within your defined range. Making good decisions and balancing your normal day-to-day activities is necessary to reduce diabetes complications. Using an insulin pump helps you manage your insulin levels while reducing the number of injections needed throughout the day.

how does an insulin pump work

But a continuous glucose monitoring (CGM) system like the Dexcom G6 helps eliminate the mystery and empowers you with the data needed to control your blood sugar levels, spot trends in how your body responds to different situations, and ultimately better manage your diabetes.

With features ranging from customizable alerts and alarms to the ability to share your numbers with up to 10 followers, the Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2 All of this without fingersticks!

The Dexcom G6 system is an easy-to-use CGM that consists of the following components:

  • A simple auto-applicator easily inserts a small sensor just beneath the skin

  • The sensor and transmitter work together to continuously measure glucose levels and send data wirelessly to the display device

  • Your display device (either the Dexcom receiver or a compatible smart device**) displays real-time glucose data

The Diabetes Care team at EHCS is ready to help you get your Dexcom G6. We work with hundreds of insurances, including Medicare and Medicaid. As a leader in diabetes care for more than 25 years, we truly understand the importance of quality products like the Dexcom G6 with personalized care. Click below to find out if you qualify for a Dexcom G6 system. After you complete the online application, EHCS will pair you with a dedicated Diabetes Care Advisor (DCA) to help you through the process. Our team of DCAs is your guide to better diabetes control from insurance approval to future supply reorders and will guide the way to better health.

Learn More about the Guardian Connect

Apply Today

Where To Place Your Insulin Pump

Insulin pump therapy provides flexibility for your lifestyle while giving you greater control of your diabetes!

  • Delivers insulin accurately and often improves your A1C

  • Eliminates individual insulin injections

  • Allows flexibility about what and you eat, making diabetes management easier

  • Eliminates unpredictable effects of intermediate or long acting insulin

SmartGuard™ Auto Mode
The MiniMed™ 670G system is the only system that automatically adjusts background insulin every five minutes based on your sugar levels.†

Benefits of the SmartGuard™ Auto Mode include:

  • Fewer highs and lows 3

  • Personalized diabetes management 3

  • More freedom to focus on your day 3, 9

  • Less effort to manage diabetes 9

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

Tags: , , , ,

Related Articles

Hyperglycemia vs. Hypoglycemia

Hyperglycemia vs. Hypoglycemia

April 04, 2022

Hyperglycemia (high blood sugar) can be a sign of diabetes onset, and it usually continues to occur on and off after you start treatment. On the other hand, hypoglycemia (low blood sugar) occurs as the result of diabetes treatment, particularly related to insulin. It is important to know the symptoms for early treatment.

hyperglycemia vs. hypoglycemia symptoms

Hyperglycemia (High Blood Glucose)

Hyperglycemia is when the body can’t use insulin properly or has too little insulin. This causes blood glucose to go above target range or higher than 160 mg/dL. It is important to know the symptoms and treatment options.

Treating Hyperglycemia

  • Be sure to drink plenty of water. It is recommended that you drink at least 8 glasses per day.

  • Ask yourself what may have caused high blood glucose/low blood glucose, and take action to correct it.

  • Try to determine if there is a pattern by checking your blood glucose.

hyperglycemia vs. hypoglycemia symptoms

hyperglycemia vs. hypoglycemia

Hypoclycemia (Low Blood Glucose)

Hypoglycemia is when your blood glucose level is less than 70 mg/dL or your blood glucose level goes below your individual target range.

Treating Hypoglycemia

With Hypoglycemia, consider the 15-15 rule: Eat 15 grams of glucose or simple carbohydrates, then wait 15 minutes and recheck glucose levels. If the level is still low, repeat.

  • Commonly used carbohydrates include glucose tablets, gel tubes, hard candies, 1 tablespoon of sugar, honey, jelly, or 4 ounces of fruit juice/regular soda.

Always consult with your doctor or diabetes educator to review your testing results if you are not sure what to do.

Is a CGM right for you?

Learn More
Tags: , ,

Related Articles

GEMCORE Starts Yearlong Celebration to Mark 30 Years

GEMCORE Starts Yearlong Celebration to Mark 30 Years

January 24, 2022

Today GEMCORE, a family of companies, starts its year-long celebration to recognize 30 years in business.

Throughout 2022, GEMCORE will share details on its rich history and recognize its team of dedicated employees through events and activities.

But a continuous glucose monitoring (CGM) system like the Dexcom G6 helps eliminate the mystery and empowers you with the data needed to control your blood sugar levels, spot trends in how your body responds to different situations, and ultimately better manage your diabetes.

With features ranging from customizable alerts and alarms to the ability to share your numbers with up to 10 followers, the Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2 All of this without fingersticks!

The Dexcom G6 system is an easy-to-use CGM that consists of the following components:

  • A simple auto-applicator easily inserts a small sensor just beneath the skin

  • The sensor and transmitter work together to continuously measure glucose levels and send data wirelessly to the display device

  • Your display device (either the Dexcom receiver or a compatible smart device**) displays real-time glucose data

The Diabetes Care team at EHCS is ready to help you get your Dexcom G6. We work with hundreds of insurances, including Medicare and Medicaid. As a leader in diabetes care for more than 25 years, we truly understand the importance of quality products like the Dexcom G6 with personalized care. Click below to find out if you qualify for a Dexcom G6 system. After you complete the online application, EHCS will pair you with a dedicated Diabetes Care Advisor (DCA) to help you through the process. Our team of DCAs is your guide to better diabetes control from insurance approval to future supply reorders and will guide the way to better health.

We are proud of our growth, of course, but it’s not about commercial success, it’s about improving the health of every person we touch.

– Matt Edwards, CEO

Devotion to the patient doesn’t diminish the importance of employees, according to Edwards. In the past few years, GEMCORE has been recognized for its dedication to its employees, customers, and industry partners through many awards, including the Weatherhead 100 Centurion Award, Inc. 5000 Fastest-Growing Company, and Top Workplace from the Cleveland Plain Dealer. These awards only tell part of the story.

“We are proud of our growth, of course, but it’s not about commercial success, it’s about improving the health of every person we touch,” Edwards said. “We are incredibly grateful to our 375 employees who made our mission theirs and who ultimately made us what we are today. Without their hard work, passion, and relentless drive, we never would have made it 30 years and counting!”

About GEMCORE

Headquartered in Hudson, Ohio, GEMCORE is a family of companies providing high quality, clinically proven, top branded medical products, medications, and innovative solutions from product fulfillment to home delivery. We work directly with patients, insurance plans, healthcare providers, manufacturers, and other partners to help lower operational costs, improve efficiencies, and increase profitability with cost-effective, results-driven solutions that ultimately improve patients’ lives. The family of companies includes Edwards Health Care Services, GemCare Wellness, GEMCO Medical, and Gem Edwards Pharmacy.

Learn more at www.gemcorehealth.com.

Tags: , ,

Related Articles

Improve Time in Range with Dexcom G6 CGM

Improve Time in Range with Dexcom G6 CGM

August 06, 2021

If you’re managing your diabetes with a blood glucose meter (BGM), you may think you have everything under control. But BGM only provides information about a single moment in time, leaving you without the ability to identify trends that can help you improve your “time in range” — the time you spend in your ideal blood glucose range.

Dexcom G6 CGM

But a continuous glucose monitoring (CGM) system like the Dexcom G6 helps eliminate the mystery and empowers you with the data needed to control your blood sugar levels, spot trends in how your body responds to different situations, and ultimately better manage your diabetes.

With features ranging from customizable alerts and alarms to the ability to share your numbers with up to 10 followers, the Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.1,2 All of this without fingersticks!

The Dexcom G6 system is an easy-to-use CGM that consists of the following components:

  • A simple auto-applicator easily inserts a small sensor just beneath the skin

  • The sensor and transmitter work together to continuously measure glucose levels and send data wirelessly to the display device

  • Your display device (either the Dexcom receiver or a compatible smart device**) displays real-time glucose data

The Diabetes Care team at EHCS is ready to help you get your Dexcom G6. We work with hundreds of insurances, including Medicare and Medicaid. As a leader in diabetes care for more than 25 years, we truly understand the importance of quality products like the Dexcom G6 with personalized care. Click below to find out if you qualify for a Dexcom G6 system. After you complete the online application, EHCS will pair you with a dedicated Diabetes Care Advisor (DCA) to help you through the process. Our team of DCAs is your guide to better diabetes control from insurance approval to future supply reorders and will guide the way to better health.

Learn More about the Guardian Connect

Apply Today
Tags: , , , ,

Related Articles

Insulin Pump & CGM Therapy for Children: The MiniMed™ 770G System

Insulin Pump & CGM Therapy for Children: The MiniMed™ 770G System

July 29, 2021

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

What Is the Guardian™ Connect System?

When using the Guardian™ Connect system you can:

  • See current glucose levels and trends at any time right on your smartphone

  • Get alerts – including predictive alerts up to 60 minutes in advance – of high and low glucose events*

  • Connect with care partners and healthcare professionals (HCPs) via the CareLink™ system platform

  • Access the Sugar.IQ™ diabetes assistant app for iOS users

Learn How The MiniMed™ 770G Insulin Pump System Can Help Your Child Prevent Glucose Highs And Lows!

Learn More about the Guardian Connect

Apply Today

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.

* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance. Based on sensor glucose values with alerts turned on.

Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.

Tags: , , , , ,

Related Articles

Your Cart